Immune-related Adverse Events and Disease Outcomes after the Third Dose of SARS-CoV-2 Mrna-Bnt162b2 Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
CANCER IMMUNOLOGY IMMUNOTHERAPY(2023)
Key words
COVID-19 vaccination,Antibody response,Cancer patients,Immune-checkpoint inhibitors,Immune-related adverse events,Disease outcomes
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined